Two Sigma Securities’s KaloBios Pharmaceuticals KBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-5,367
Closed -$21K – 333
2015
Q1
$21K Buy
+5,367
New +$24.1K 0.02% 176

Other funds holding KBIO

Two Sigma Securities's KBIO Position: Q2 2015 in Review

Two Sigma Securities sold out of KaloBios Pharmaceuticals (KBIO) in Q2 2015, closing a stake of 5,367 shares — an estimated $21K sold.

Two Sigma Securities first reported a position in KBIO in Q1 2015 and held it in 1 quarter. The position peaked at $21K in Q1 2015. 19 funds tracked by Wall St. Rank hold KBIO as of Q2 2015.

  • Two Sigma Securities reported no remaining KaloBios Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Two Sigma Securities sold 5,367 KaloBios Pharmaceuticals shares in Q2 2015, an estimated $21K.
  • Two Sigma Securities first reported a position in KaloBios Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Two Sigma Securities's KaloBios Pharmaceuticals position peaked at $21K in Q1 2015.
  • 19 funds tracked by Wall St. Rank held KaloBios Pharmaceuticals as of Q2 2015.

Based on Two Sigma Securities's 13F filing for Q2 2015, filed 14 Aug 2015.